NCT05219604View on ClinicalTrials.gov

Central Nervous System Effects Following Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling

PHASE4TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

October 4, 2022

Study Completion Date

October 4, 2022

Conditions
Central Nervous System Effects of DiphenhydraminePharmacokinetics of Diphenhydramine
Interventions
DRUG

DiphenhydrAMINE Injectable Solution

Intravenous infusion of diphenhydramine 50 mg.

Trial Locations (1)

14226

Dent Neurologic Institute, Amherst

Sponsors
All Listed Sponsors
lead

Dent Neuroscience Research Center

OTHER

NCT05219604 - Central Nervous System Effects Following Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling | Biotech Hunter | Biotech Hunter